Company profile: Physidia
1.1 - Company Overview
Company description
- Provider of nephrology and home dialysis medical equipment, tools and training, including the S3 Monitor for daily home hemodialysis, SeCoHD therapy, home delivery of disposables, remote supervision transmitting session data to dialysis centers, and a technical hotline.
Products and services
- SeCoHD Therapy: A back-filtration/ultrafiltration-based method that enhances removal of uremic toxins without using additional replacement fluids, employing alternating cycles to improve clearance during dialysis treatments
- S3 Monitor: A compact, home-hemodialysis device enabling patients to perform dialysis sessions independently and adjust schedules to personal needs, facilitating daily treatments with patient-led operation
- Remote Supervision: An integrated data-transmission feature of the S3 monitor that sends dialysis session data to the dialysis center, enabling remote monitoring and support by medical professionals throughout sessions
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Physidia
Hemotune
HQ: Switzerland
Website
- Description: Provider of a therapeutic blood purification platform and products: HemoSystem using magnetic beads to selectively remove large biomolecules for conditions like sepsis; HemoBeads with ultra-magnetic cores and affinity binders; HemoDevice, a reusable extracorporeal device; HemoDisposable sterile single-use tubing; and reSEPT Therapy to restore immune balance in septic shock.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hemotune company profile →
Cadrenal Therapeutics
HQ: United States
Website
- Description: Provider of Tecarfarin, a late-stage novel oral anticoagulant targeting a different metabolic pathway than warfarin for patients with end-stage kidney disease (ESKD) and atrial fibrillation (AFib). Under development for anticoagulation needs of left ventricular assist device (LVAD) patients and those with Antiphospholipid Syndrome (APS), aiming for safer alternatives to warfarin.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cadrenal Therapeutics company profile →
Potrero Medical
HQ: United States
Website
- Description: Provider of predictive health technologies developing smart sensors and AI, including the Accuryn Monitoring System for real-time monitoring of urine output, intra-abdominal pressure, and core body temperature to detect acute kidney injury risk; AccuTab software for visualizing and annotating data; and Accuryn SmartFoley catheters designed to reduce CAUTIs by preventing urine backflow.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Potrero Medical company profile →
Theradial
HQ: France
Website
- Description: Provider of medical devices in France serving health actors in dialysis-nephrology, gastroenterology and onco-hematology. Offers Renoral nutritional supplement for hemodialysis patients; Hemadialyse and MEDWARE software for patient data/records; Théradata CNIL-authorized nephrology-dialysis data repository; InBody S10 and InBody BWA 2.0 bioimpedance analyzers, and partners with the medical and scientific community via clinical studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Theradial company profile →
MediBeacon
HQ: United States
Website
- Description: Provider of optical diagnostic solutions for non-invasive organ function measurement, including the Transdermal GFR Measurement System (TGFR) that assesses kidney function via a fluorescent tracer (Lumitrace) detected through the skin, plus TGFR Sensors and Monitors for real-time data. Also offers novel fluorescent tracer agents and highly engineered transdermal sensors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MediBeacon company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Physidia
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Physidia
2.2 - Growth funds investing in similar companies to Physidia
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Physidia
4.2 - Public trading comparable groups for Physidia
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →